The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain
Clinical trials of rotigotine extended-release microspheres (RTGT-MS), which provides a sustained release of rotigotine for near 2 weeks in vivo, have been conducted in the treatment of Parkinson's disease (PD). This study was to investigate the analgesic effect of RTGT-MS, and to know whether...
Saved in:
Main Authors: | Keke Li (Author), Yijia Zhang (Author), Enming Tian (Author), Zikai Liu (Author), Tian Wang (Author), Fenghua Fu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats
by: Mao Yutong, et al.
Published: (2023) -
Using Polymers as Crystal Inhibitors to Prevent the Crystallization of the Rotigotine Patch
by: Qiantong Liu, et al.
Published: (2024) -
Prospective Evaluation of Local Sustained Release of Celecoxib in Dogs with Low Back Pain
by: Tijn Wiersema, et al.
Published: (2021) -
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
by: Ronan Talty, et al.
Published: (2022) -
Insulin-loaded PLGA microspheres for glucose-responsive release
by: Jun-Zi Wu, et al.
Published: (2017)